Background. The role of lipoprotein disturbances in the development of peripheral vascular disease (PVD) has not been sufficiently clarified.
Background. The role of lipoprotein disturbances in the development of peripheral vascular disease (PVD) has not been sufficiently clarified. Methods and Results. The relations among concentrations of intermediate density lipoproteins (IDL), apoprotein (apo) B, apo E, and other lipoproteins were studied in 102 men with PVD and 100 healthy men who formed the control group. Patients with PVD had significantly higher levels of serum triglycerides, very low density lipoprotein (VLDL) cholesterol, VLDL triglycerides, VLDL proteins, IDL cholesterol, and IDL triglycerides and lower levels of high density lipoproteins (HDL) than controls. Serum cholesterol and triglycerides were normal in 30 patients (cholesterol, <5.2 mmol/l; triglycerides, <2.3 mmol/1), who had significant increases in IDL triglycerides and significant decreases in HDL cholesterol compared with the 47 controls, who had normal cholesterol and triglyceride levels. Patients with more severe distal involvement showed higher cholesterol and triglycerides carried by IDL and a greater reduction in HDL cholesterol. Smoking patients with PVD showed increased VLDL cholesterol and VLDL triglycerides and lower HDL concentrations. Apo E polymorphism in our study population does not differ from that reported for other European populations. Alleles 62 and 64 had a major impact on serum triglycerides and VLDL lipids in our patients with PVD.
Conclusions. Lipoprotein disturbances are a major risk factor for PVD. IDL abnormalities play an important role in the development and severity of PVD and should also be considered a vascular risk factor in normocholesterolemic and normotriglyceridemic patients. (Circulaion 1992;85: [30] [31] [32] [33] [34] [35] [36] I ntermediate density lipoproteins (IDL) are defined as lipoproteins with a buoyant density of 1.006-1.019 g/ml. These particles have generally been regarded as a single class of lipoproteins produced from the catabolism of veiy low density lipoproteins (VLDL).l The resultant IDL is rapidly taken up by the liver or transformed into low density lipoproteins (LDL) and thus is detectable in normal plasma at low concentrations. At present, it is well established that apoprotein (apo) E plays an essential role in IDL clearance through E and B-E liver receptors. Three major isoforms of apo E, designated E2, E3, and E4, have been identified by isoelectric focusing.2 Recently, isoforms of apo E as well as abnormalities in IDL composition have been related to being at risk for coronary heart disease (CHD). 3, 4 The high incidence of peripheral vascular disease (PVD) in smokers and patients with diabetes mellitus is well known.5 With regard to lipoprotein disturbances, PVD is closely related to low levels of high density lipoproteins (HDL) and raised triglycerides carried by VLDL.6-8 There is general agreement that PVD, compared with CHD, appears to be unrelated to LDL concentration,9-11 but a recent study found a positive LDL association only in women with severe disease.8 On the other hand, there are no data concerning the role of IDL and isoforms of apo E in the development of PVD.
The aim of the present study was to evaluate lipoprotein abnormalities and their relation with apo E phenotypes and the severity of the disease in men with PVD. 
Methods

Subjects
One hundred two outpatient men (age range, 44-87 years; mean age, 67 years) with PVD were studied. The diagnosis of PVD was established by clinical history, physical examination, and Doppler pressure at rest and after exercise with stress testing.12 Twenty-two patients had aortoiliac involvement according to the femoral waveform,13 and the remaining 80 patients with distal involvement were classified according to the ankle/brachial index (ABI) as having moderate (ABI, 0.6-0.9) or severe (ABI, 0.5 or less) ischemia. 12 The results of Doppler examination of the lower limbs had remained constant throughout the 6 months before the study. Angiography was performed in 62 patients, and the diagnosis was confirmed in all. Mean+SD body mass index of patients was 22.5+2.3. Patients with CHD, cerebrovascular disease, diabetes mellitus, autoimmunovascular, liver, renal, or other endocrine diseases were excluded. Fourteen patients (13.7%) had never been smokers, and smoking history was recorded in 88 patients (86.3%); 58 of them were smokers at the time of the study. One hundred healthy men (age range, 42-89 years; mean age, 66 years) were used as controls; 39% had never been smokers, 26% were exsmokers, and 35% were current smokers. Mean body mass index of controls was 22.8+2.1. Exclusion criteria (for both patients and controls) were alcohol consumption of more than 40 g/day, body mass index of more than 25, or both. None of the subjects was receiving therapy known to cause changes in lipid and lipoprotein profiles.
Lipoprotein Analysis
Blood samples were obtained in the morning after an overnight fast, subjects were seated during phlebotomy, and serum was collected. VLDL fraction (d<1.006 g/ml) was isolated by preparative ultracen-trifugation14 in an ultracentrifuge Centrikon T-1055 (Kontron Instruments, Milan, Italy) using a TFT 50.38 rotor (Kontron Instruments). The other lipoproteins (IDL, 1.006<d<1.019 g/ml; LDL, 1.019<d<1.063 g/ml; HDL, d>1.063 g/ml) were isolated by density gradient ultracentrifugationl5,16 in a TST 41.14 rotor. Cholesterol and triglycerides in serum and lipoprotein fractions were assayed by enzymatic methods17"18 using a selective multichannel analyzer Eris (Eppendorf, Hamburg, FRG) and standardized with control sera (Qualitrol, Merck, Frankfurt, FRG). Proteins of each isolated fraction were determined by a colori- 
Results
Serum Lipid, Lipoprotein, and Apoprotein Concentrations
Serum triglycerides and lipids carried by VLDL and IDL were significantly increased in patients with PVD, whereas HDL levels were decreased (Table 1) . Other lipid, lipoprotein, and apoprotein concentrations as well as VLDL triglycerides-to-HDL choles- Values are given as mean+SD mmol/1 (lipids) and g/l (proteins). Values are given as mean+SD mmol/l (lipids) and g/l (proteins).
terol ratios in patients and controls are also shown in Table 1 . Positive correlations between IDL and VLDL as well as between LDL triglycerides and IDL triglycerides are observed in patients with PVD ( Table 2 ). In addition, HDL and IDL cholesterol are inversely correlated with triglyceride-rich lipoproteins and LDL cholesterol, respectively. To assess lipoprotein abnormalities in normolipemic subjects, a subgroup of 30 PVD patients and 47 controls with cholesterol serum levels lower than 5.2 mmol/l and triglycerides below 2.3 mmol/l, was analyzed. Lipids and proteins in lipoprotein fractions showed no significant differences between patients and controls, except for IDL triglycerides with mean+SD values of 0.16+0.09 mmol/1 in patients and 0.12+0.08 mmol/1 in controls (p<0.005) and HDL cholesterol levels of 0.91+0.26 and 1.06+0.26 mmolI1 (p<0.05), respectively. Mean±tSD VLDL triglycerides-to-HDL cholesterol ratio was 0.64±0.42 in these patients versus 0.46±0.32 in controls (p<0.05).
Lipid and lipoprotein concentrations in the 80 patients with distal involvement, classified as moderate or severe vascular ischemia according to ABI measured by Doppler,13 are shown in Table 3 . IDL levels were significantly higher and HDL cholesterol levels were lower in patients with severe ischemia than in those with moderate ischemia.
Lipids, Smoking and PVD
Comparing exsmokers with nonsmoking patients, no significant differences in lipid and lipoprotein concentrations were found. Serum triglycerides, VLDL triglycerides, and VLDL triglycerides-to-HDL cholesterol ratio were significantly increased in smoking patients compared with exsmokers and nonsmokers, whereas HDL cholesterol was decreased in the smokers compared with the exsmokers and nonsmokers, as shown in Table 4 . To assess the effect of smoking in lipoprotein profile, we have stratified case-control comparisons by smoking status (Table  4 ). In this regard, only IDL triglyceride levels were associated with PVD independently of the smoking status.
No significant differences were observed when the lipid and lipoprotein composition, including IDL, was compared between smokers and nonsmokers of the control group.
PVD and Apoprotein E Phenotypes
Apo E phenotypes in controls were distributed as follows: 13% E3/E2, 70% E3/E3, 2% E4/E2, 12% E4/E3, and 3% E4/E4. This distribution did not differ from that of the patients with PVD (15.7% E3/E2, 63.7% E3/E3, 1.9% E4/E2, 16.7% E4/E3, and 1.9% E4/E4). According to the apo E phenotypes, lipid and lipoprotein concentrations show no significant differences in the control group (Table 5) . Lipid and lipoprotein concentrations in patients with PVD classified according to the apo E phenotypes and differences from controls are shown in Table 6 . The genetic polymorphism of apo E in patients significantly influenced triglycerides and VLDL triglycerides. Interestingly, IDL triglycerides are significantly increased in patients with E3/E2 and E3/E3 phenotypes as compared with controls with the same phenotypes. However, no differences were observed when IDL triglycerides were compared among the different phenotypes in patients.
Discussion
Smoking and diabetes mellitus constitute risk factors for PVD. On the other hand, the roles of lipid and lipoprotein disturbances in the development of PVD have not been sufficiently clarified. Nevertheless, the constant finding of increased triglyceride serum concentrations in PVD should be emphasized.8'23 An attractive hypothesis would be to assume that triglycerides constitute an important risk factor for CHD,24-26 although their independent effect in PVD has not been adequately analyzed. In the present study, we observed an evident relationship between PVD and an increase in serum triglycerides and triglycerides carried by VLDL.
In agreement with previous data,9-11 no abnormalities in LDL composition have been observed in men with PVD. On the other hand, the role of HDL has not been widely studied, but lower mean concentrations have been found, [6] [7] [8] 2728 as occurred in the present study, as well as a high inverse correlation of HDL with triglyceride-rich lipoproteins.
Recently, the Cholesterol Lowering Atherosclerosis Study29 supported the hypothesis that at least some Values are given as mean±SD mmol/l (lipids) and g/l (proteins). *Comparison between phenotypes E-4/E-3 and E-3/E-2 versus phenotype E-3/E-3. t and t, significantly different from controls (see Table 5 ) with the same phenotype (p<0.05 and p<0.01, respectively).
VLDL species, such as those enriched by cholesterol, are atherogenic. In this respect, in the present study, cholesterol carried by VLDL was increased in patients with PVD compared with controls, which supports the abovementioned hypothesis. Besides familial dysbetalipoproteinemia, other abnormalities in IDL composition in patients with chronic renal failure and diabetes mellitus have been described that may contribute to the development of atherosclerosis in these patients. 30, 31 Similarly, abnormalities in IDL composition in patients with CHD have been reported,4'25,32 and recent evidence points to a close relation between IDL and CHD in hypercholesterolemic33 as well as normo-cholesterolemic4 patients. In the present study, we found increases in IDL cholesterol and IDL triglycerides with a positive correlation between IDL and VLDL and an inverse correlation between IDL cholesterol and LDL cholesterol in patients with PVD. On the other hand, it is noteworthy that patients with more severe distal involvement showed higher cholesterol and triglycerides carried by IDL and a greater reduction in HDL cholesterol. The atherogenic potential of triglyceride-rich lipoproteins might be due to alterations in the catabolism of these lipoproteins or their remnants, as has been observed in patients with hypertriglyceridemia34 and healthy individuals after a fatty meal. 35 Furthermore, VLDL triglycerides-to-HDL cholesterol ratio, which reflects triglyceride ca-tabolism,36 was significantly higher in the entire group of PVD patients and even normotriglycendemic patients, suggesting impaired metabolism of triglyceriderich lipoproteins. The influence of smoking on the lipid profile is well known. In this respect, an increase in triglyceriderich lipoproteins37 and differing results with respect to HDL have been described. 25 In the present study, smoking in PVD patients was associated significantly with increases in VLDL cholesterol and VLDL triglycerides and with a decrease in HDL. However, the fact that no differences were observed when these lipoproteins were compared between patients and controls, both exsmokers and nonsmokers, suggests that they are influenced by smoking. On the other hand, the only lipidic parameter that showed significant differences according to smoking status in patients and controls was IDL triglycerides (Table 4 ). This finding suggests that IDL triglycerides' association with PVD is independent of smoking.
The prevalence of the apo E phenotypes in our study population was similar to those reported in other European populations.38-40 Allele E2 has been associated with reduced risk for CHD, and allele E4 has been associated with increased risk.3 In the present study, alleles E4 and E2 apparently had a major impact on serum triglycerides and VLDL lipids in patients with PVD, since these differences were not found in the control group. Furthermore, the fact that VLDL is increased in patients with phenotypes E4/E3 and E3/E2 might account for both phenotypes having a similar risk for PVD. In the other hand, the increased levels of IDL triglycerides associated with PVD, in absence of differences according to the different phenotypes, cannot be explained by apo E polymorphism alone.
In addition to smoking and diabetes mellitus, the present study emphasizes the role of lipoprotein disturbances as a major risk factor for PVD. Therefore, the decrease in HDL as well as the increase in triglyceride-rich lipoproteins in men with PVD is noteworthy. The association of IDL with PVD may be important when considering the relation between hypertriglyceridemia and atherosclerosis of the lower limbs, as described for CHD.29 In the present study, the fact that IDL abnormalities were also found in a subgroup of patients with normocholesterolemia and normotriglyceridemia led us to consider them risk factors for atherosclerosis.
